Connelly to lead Lilly’s U.S. unit, joins elite group

Share this article:
Eli Lilly yesterday named Deirdre Connelly president of Lilly USA.
The role gives Connelly direct responsibility for an affiliate that generated $7 billion in 2004 sales and has 6,600 employees.
In the process, Connelly joins an elite and growing band of female pharma execs, including Christine Poon, worldwide chairman of medicines and nutritionals at Johnson & Johnson, Karen Katen, vice chairman of Pfizer, Margaret McGlynn, president of U.S. Human Health Care at Merck, and Carrie Cox, president, global pharmaceutical business at Schering-Plough.
Connelly was promoted from the position of senior vice president for human resources, which she held only since last August. Succeeding her in that role is Anthony Murphy, formerly executive director for human resources.
She reports to John Lechleiter, executive vice president of pharmaceutical operations, who has had the additional task of leading U.S. operations since last July.
After joining Lilly's field force in 1984, Connelly held various positions, including leader of its U.S. women's health business unit and executive director of human resources for Lilly USA.
Share this article:

Email Newsletters

More in News

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.

Amgen Q2 sales rise, company to lay off up to 2,900

Amgen Q2 sales rise, company to lay off ...

The majority of the layoffs will be in the US.

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...